LifeScan recently announced the US launch of the OneTouch Verio Blood Glucose Monitoring System. The system is now available nationwide at an estimated retail price of $19.99.
In a landmark new study, researchers found that babies who consumed the equivalent of about 4 heaping teaspoons of peanut butter each week, starting when they were between 4 and 11 months old, were about 80 percent less likely to develop a peanut allergy by age 5.
Around 86 million people in the US have prediabetes, putting them at higher risk of being diagnosed with diabetes in the future. But a research team led by investigators from the University of Michigan Medical School has created a “precision medicine” model that they say could aid diabetes prevention in high-risk individuals by identifying the […]
Medtronic is touting new data that shows its MiniMed 530G pump, which automatically suspends insulin delivery when blood sugar levels get too low, can prevent some bouts of hypoglycemia. While previous clinical trials resulted in similar findings, this study confirmed hypoglycemia reduction in a real world setting.
UCLA researchers randomly assigned a small group of 49 volunteers, aged 55 and older, who suffered from moderate sleep issues to receive training in mindfulness meditation or in improving basic sleep habits. The meditation didn’t require a mantra.
Researchers at the University of Massachusetts Medical School in Worcester found that people who ate 30 grams of fiber per day lost just about as much weight as those who followed a more complicated diet.
The common belief, presently held by many endocrinologists, is that test blood, drawn from the fingertips, gives a more current and accurate indication of blood glucose than blood drawn from alternate sites, such as the forearm, shoulder and stomach.
Dietary supplements are not miracle pills. Extremely few of the claims are supported by good science, even when the substance on the label is actually in the bottle (which we’ve learned we don’t know for sure), and many others have been proven ineffective.
Super obese patients with diabetes may not get the same benefits from bariatric surgery as those who with BMIs less than 62, according to published research.
You can dramatically reduce your chances of having heart disease or dying from heart disease if you do six simple things. That’s what a new study in the recent edition of the Journal of the American College of Cardiology found.
There’s always a fair amount of buzz and excitement whenever a “next-generation” diabetes device is announced, or talked about for the first time. They often get big play in the mainstream press despite still being a long ways from available on the market for patients to access and use.
Women with type 1 diabetes face a greater risk of dying from a range of diseases compared with men with the same condition, research suggests.
Instead of repeated blood tests and injections throughout the day to keep blood sugar in check, a single dose of smart insulin would keep circulating in the body and turn on when needed. Animal studies show the technology appears to work – at least in mice.
Already approved by the FDA, the app is slated to debut in April to help diabetics make sure their blood sugar levels don’t go too high or too low.
Take a deep breath, Friends: the world’s first (seemingly) commercially viable inhalable insulin product is here. Today, Sanofi has officially launched MannKind’s long-awaited Afrezza, and we hear the product is already appearing in some pharmacies nationwide. Housed in a tiny, handy inhaler device, Afrezza is said to bring not only convenience, but also some new […]
Intarcia Therapeutics just released the latest data from its phase 3 FREEDOM-1 trial of ITCA-650, a small implanted device to treat type 2 diabetes. The tiny device is implanted under the skin for three or six months and continuously releases exenatide (a GLP-1 agonist) through a small mini-pump.
In some young children who develop type 1 diabetes, a change in normal stomach bacteria can precede the disease by a year, a small study has found. The findings, published Feb. 5 in the journal Cell, Host & Microbe, are based on just 33 children at increased genetic risk of type 1 diabetes . And […]
The technique involves the examination of unmyelinated nerve fibers at high magnification using a laser-scanning corneal confocal microscope to image the subbasal nerve plexus of the patient’s cornea. Increased severity of diabetic peripheral neuropathy is associated with reduced corneal-nerve fiber length and corneal sensitivity.
Medtronic Diabetes shared new timeline hopes on its upcoming diabetes device pipeline at the JP Morgan Healthcare Conference on January 12. Notably, management expects to launch the MiniMed 640G/Enlite 3 CGM (predictive low glucose management) in the US by April 2016, and a hybrid closed loop system (one step closer to a fully automated ‘artificial […]
Every person who uses insulin to manage diabetes wants what they don’t have — a replacement for their malfunctioning pancreas. And though the technology isn’t yet to the point of creating an artificial pancreas, it’s getting a lot closer.